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Abstract
The effects of type II diabetes on cardiac creatine kinase (CK) enzyme activity
and/or flux are unknown. We therefore measured steady-state phosphocrea-
tine (PCr) and adenosine triphosphate (ATP) content and forward CK reac-
tion kinetic parameters in Zucker Diabetic Fatty (ZDF) rat hearts, a type II
diabetes research model. At baseline the PCr to ATP ratio (PCr/ATP) was sig-
nificantly lower in diabetic heart when compared with matched controls
(1.71  0.21 vs. 2.26  0.24, P < 0.01). Furthermore, the forward CK
reaction rate constant (kf) was higher in diabetic animals (0.52  0.09 s1
vs. 0.35  0.06 s1, P < 0.01) and CK flux calculated as a product of PCr
concentration ([PCr]) and kf was similar between two groups (4.32 
1.05 lmol/g/s vs. 4.94  1.23 lmol/g/s, P = 0.20). Dobutamine administra-
tion resulted in similar increases in heart rate (~38%) and kf (~0.12 s
1) in
both groups. No significant change in PCr and ATP content was observed
with dobutamine. In summary, our data showed reduced PCr/ATP in diabetic
myocardium as an indicator of cardiac energy deficit. The forward CK reac-
tion rate constant is elevated at baseline which might reflect a compensatory
mechanics to support energy flux through the CK shuttle and maintain con-
stant ATP supply. When hearts were stimulated similar increase in kf was
observed in both groups thus it seems that CK shuttle does not limit ATP
supply for the range of workload studied.
Introduction
In recent years the number of patients suffering from
Type II diabetes mellitus (T2DM) has reached dramatic
proportions. Cardiovascular disease is the leading cause of
death in diabetic subjects with hypertension and athero-
sclerosis as the major contributing factors (Haffner et al.
1998; Chen et al. 2011). However, even after controlling
for these comorbidities there is an increased incidence of
heart failure in diabetic subjects and this is characterized
as diabetic cardiomyopathy (DCM) (Bell 2003; Miki et al.
2013). DCM is associated with abnormalities in contrac-
tility (diastolic dysfunction which may precede the devel-
opment of systolic dysfunction) and energy metabolism
(Taegtmeyer et al. 2002; Young et al. 2002; Cosson and
Kevorkian 2003). In particular, several studies in strepto-
zotocin (STZ)-treated diabetic rat hearts have reported
reduced CK activity and decrease in CK isoenzyme con-
tent (Savabi 1988; Popovich et al. 1989; Awaji et al. 1990;
Savabi and Kirsch 1991). In contrast Lin et al. (2009)
have recently reported reduced levels of phosphorylation
of enzyme in diabetic hearts resulting in about 70%
increase in the forward CK activity (forward CK reaction
is defined as using PCr to produce ATP i.e., PCr--> ATP
exchange). Another study has also reported differential
modulation of CK activity with diabetes and a 50%
increase in CK activity was observed in left ventricles of
8-week diabetic rat hearts (Somjen et al. 2006). This con-
flicting data could be due to several reasons; different
enzymatic essays used in the studies, reporting of forward
versus reverse enzyme activity, severity, duration, and the
etiology of diabetes.
Two previous studies employed 31P MRS to directly
measure the forward CK reaction kinetics in isolated
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perfused type I diabetic rat hearts (Matsumoto et al.
1995; Spindler et al. 1999). The forward velocity of CK
reaction was reduced by about 30% in both the studies. A
major limitation of these studies is that the spontaneous
heart rate of the perfused diabetic heart was approxi-
mately 30% lower than the age-matched controls and iso-
lated hearts became functionally incompetent when paced
at normal rate. Since CK reaction kinetics is closely cou-
pled to the rate of ATP production therefore hearts work-
ing at different loads complicates the interpretation of the
data from these experiments (Bittl and Ingwall 1985).
These studies also reported contradictory results at ele-
vated work presumably due to difficulty in maintaining
the viability of isolated diabetic heart.
Spatially localized 31P MRS has been used for a long
time to noninvasively measure cardiac high-energy phos-
phate metabolites in vivo. These studies have been largely
limited to the measurement of cardiac PCr/ATP ratios
and absolute content (Maslov et al. 2010). Recently rates
of ATP synthesis through CK shuttle for in vivo mouse
heart have been reported and are significantly reduced in
thoracic aortic constriction model of heart failure (Gupta
et al. 2011). We have two aims in this study: First is to
adapt the 31P MRS technique, we had previously devel-
oped for human studies, to measure CK flux in rat hearts
(Bashir and Gropler 2014). Second aim of the project was
to test the hypothesis that in vivo myocardial CK reaction
kinetics are reduced in animal model of T2DM. We chose
type II diabetes because (1) CK reaction kinetics in type
II diabetic hearts has not been studied before, and (2)
T2DM accounts for over 90% of diabetes cases in
humans. 31P saturation transfer measurements were made
at rest and during infusion of dobutamine to increase car-
diac workload which would yield important information
about the CK shuttle response to an adrenergic stress.
Materials and Methods
Animal preparation
Animal experiments were approved by the Animal Studies
Committee of Washington University in St. Louis and
comply with the standards in the Guide and the Animal
Welfare Act. Male Zucker Diabetic Fatty (ZDF) rats and
their lean littermates were obtained from Charles River
Laboratories, Inc. (Wilmington, MA) and maintained on
Purina 5008 chow. On this diet, ZDF rats develop diabe-
tes at 12 weeks of age; hence, all studies were done when
the rats were 14–15 weeks old. All animals were provided
food and water ad libitum at all times except during
imaging. The animals were anesthetized using 2% isoflu-
rane, which was maintained throughout the experimental
session. Blood glucose levels were assessed with a Bayer
Contour blood glucose monitoring system (Bayer Health-
Care LLC, Mishawaka, IN). An IV catheter was placed in
the tail vein and flushed with heparin/saline solution was
used to administer dobutamine. The temperature was
maintained by water blanket and constantly monitored
during the scan. The heart rate was monitored using an
MR-compatible small animal monitoring and gating Sys-
tem (SA Instruments, Inc.)
In vivo 31P MRS
MRS experiments were performed at 81.5 MHz using an
Agilent/Varian 4.7T system (Santa Clara, CA). A 2.4 cm
diameter 31P surface coil and a geometrically decoupled
4 9 6 cm butterfly proton (1H) surface coil were posi-
tioned directly beneath the chest of the animal, which was
in a prone position. 1H MR anatomical images were first
acquired to determine positioning of the RF coils. A fiducial
attached to the center of the coil was used as a reference to
accurately adjust the coil position relative to heart. Adjust-
ment of field homogeneity was performed manually by opti-
mizing the 1H signal. The 31P signal was localized to the
myocardial tissue using the sensitivity profile of the 13P sur-
face coil in combination with suppression of signals from
superficial (chest) tissues. This was achieved via a modified
1D-ISIS localization consisting of two scans. In the first scan
all the spins within the sensitive region of the RF coil were
excited. During the second acquisition the spin population
within the superficial tissue was inverted with a B1 insensi-
tive adiabatic full passage pulse (AFP) in the presence of lin-
ear gradients. After the spins were spatially encoded, a
spoiling gradient was applied to dephase any residual trans-
verse component. Addition of the two scans was used to
eliminate the signal from selected region. The performance
of this approach was tested in a two compartment phantom
consisting of stack of 0.5 cm disks containing phenylphos-
phonic acid (C6H7O3P) and sodium phosphate (Na2HPO4).
Area under the resonances was used to determine the rela-
tive phosphate content and signal contamination was deter-
mined as the area of the resonance from bottom phantom
divided by the total area under the resonances.
In vivo 31P MRS data were acquired using a 1 ms 90°
adiabatic excitation pulse. Saturation transfer was
obtained by low power, narrow band saturation pulse
centered on the c-ATP resonance for 0.2, 0.4, 0.7, 1.6,
2.2, 3, 6, and 9 s. This narrow band pulse directly attenu-
ated the PCr signal by <5%. Data were acquired with an
inter-pulse delay of 9 s and a spectral width of 3000 Hz,
with 64 transients acquired for each saturation time. This
resulted in a total data acquisition time of about 1.5 h.
Immediately after acquiring the baseline measurements
dobutamine was infused, in a subset of animals, using a
syringe pump (Harvard Clinical Technology, South
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Natick, MA) via tail vein catheter at a constant rate of
20 lg/kg/min. 31P data acquisition started after a stable
heart rate was achieved approximately 5 min after the
start of infusion. At the end of experiment animals were
allowed to recover in room air and placed in their cages.
Data analysis
The spectra were processed in the time domain by AMARES
(advanced method for accurate, robust, and efficient spec-
tral fitting) algorithm implemented in jMRUI software
package (Vanhamme et al. 1997; Naressi et al. 2001). Reso-
nances peaks were fitted to Lorentzian line shapes and soft
constraints on the resonance frequencies were used to con-
strain the fit. For the saturation transfer experiments the
PCr line-width was constrained to the line-width of control
spectra obtained from an unconstrained fit.
Uncalibrated PCr and ATP content in myocardium was
measured as the relative area of the respective resonances.
Absolute PCr concentration ([PCr]) was calculated making
a standard assumption that ATP concentration is
5.5 lmol/g wet weight (8.2 mmol/L cell water) in myocar-
dium (Neubauer 1999; Hitchins et al. 2001; Beer et al.
2002; Kemp et al. 2007; Gupta et al. 2011; El-Sharkawy
et al. 2013). This assumption is commonly used and a
range of laboratories and groups that have worked in this
area have demonstrated that the myocardial ATP levels
remain at normal level until the advanced stages of heart
failure (Nascimben et al. 1996; Neubauer 1999). This ATP
concentrations are also shown to be remarkably similar in
hearts between different animal species and humans despite
large differences in size and heart rate. Adenosine Diphos-
phate concentration ([ADP]) was calculated from CK equi-
librium equation by [ADP] = ([TCr]/[PCr]  1)*([ATP]/
(Keq*H
+)) where total creatine ([TCr] = [PCr] + [Cr]) is
32 mmol/L, and Keq = 1.66 9 10
9 mol L1 at pH 7 (Ing-
wall 2002, 2009).
The magnetization of PCr falls exponentially when
c-ATP resonance is saturated and the PCr single intensity
was fit to M(t) = Mss + A.exp(s.t) where s = kf + R1 (s1)
is the apparent relaxation rate constant in presence of
exchange and Mss is the steady-state magnetization with
c-ATP saturated, kf (s
1) is the forward (PCr to ATP)
chemical reaction rate constant of CK and R1 (s
1) is the
intrinsic relaxation rate constant of PCr in absence of
exchange. The CK reaction rate constant was then deter-
mined using the following equation




where Mo is the control PCr intensity in the absence of a
saturation pulse (Alger and Shulman 1984; Kuchel 1990).
Data are provided as mean  SD. Unpaired t-test was
performed to test the differences within the groups (rest
vs. stress) and between groups (lean vs. obese).
Results
Characteristics of the control and diabetic rats are given
in Table 1. There were no significant differences between
the two groups in resting heart rate or bodyweight,
although the ZDF rats tended to be a little heavier. The
obese rats were hyperglycemic, consistent with their dia-
betic phenotype. There was a significant increase in heart
rate with infusion of dobutamine. The temperature of the
animals remained stable during the experiment (data not
shown).
Figure 1 shows the MR image of the two compartment
phantom and spectra acquired in the absence (Fig. 1B) or
presence (Fig. 1C) of the saturation band. Spectra show
that the resonance from sodium phosphate was elimi-
nated when the saturation region was placed on the bot-
tom compartment. The signal contamination, expressed
as a percentage of the total signal, was <3% for a typical
experiment. Figure 2A and B show high-resolution sagit-
tal and axial images of the heart obtained using the 1H
surface coil. 31P spectra from heart under different satu-
rating conditions is shown in Figs 2C and PCr resonance
amplitude diminishes as the duration of c-ATP saturation
is increased. Figure 2D shows a graph of PCr resonance
intensity versus saturation time and the resulting expo-
nential fit.
Diabetic rats had significantly lower [PCr] (9.43  1.17
vs. 12.46  1.34 lmol/g wet weight; P < 0.01) and PCr/
ATP ratio (1.71  0.21 vs. 2.26  0.24; P < 0.01) than
age-matched lean rats. Dobutamine administration
resulted in a ~40% increase in heart rate in both groups
but PCr content and the PCr/ATP ratio were not affected
(Fig. 3). Myocardial [ATP] was similar between the two
groups (P = 0.2) whereas [ADP] concentration at baseline
were significantly higher in myocardium from obese rats
(51.64  5.00 vs. 35.75  5.32 lmol/L; P < 0.01).
The kinetic data showed significant differences in the
forward first-order rate constant of the CK reaction (kf)
between obese and lean rats. At baseline the kf was
significantly higher in diabetic myocardium when com-
pared to the age-matched lean rats (0.52  0.09 s1 vs.
0.35  0.06 s1; P < 0.01). The reaction rate constant
increased in both lean (0.35  0.06 s1 to 0.44  0.09 s1;
P < 0.01) and diabetic (0.52  0.09 s1 to 0.65 
0.11 s1; P = 0.02) hearts with dobutamine stress. The
mean in vivo forward rate of ATP synthesis through car-
diac CK at rest was 4.94  1.23 lmol/g/s in obese rats
and 4.32  1.05 lmol/g/s in lean rats (P = 0.24). R1 for
PCr was indistinguishable between the two groups
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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(lean = 0.26  0.04 s1 vs. obese = 0.29  0.06 s1,
P = 0.22) and did not change with dobutamine stress
(Fig. 4).
Discussion
We demonstrated successful measurement of rate of ATP
synthesis through CK in rat model of type II diabetes
using noninvasive saturation transfer 31P MRS. In this
study we found that PCr concentration and PCr/ATP
ratio is significantly reduced in obese T2DM rat hearts as
compared to those from lean age-matched control rats.
We further found that pseudo-first-order forward rate CK
reaction rate constant (kf) is higher in ZDF diabetic rat
hearts as compared to lean control animals. These results
disprove our original hypothesis that CK flux ZDF rat
hearts will be reduced. Our results also contradict previ-
ous reports of reduced CK reaction kinetics in type I dia-
betic rat hearts (Popovich et al. 1989; Matsumoto et al.
1995; Spindler et al. 1999). Dobutamine stress resulted in
approximately similar increase in kf in both groups,
whereas PCr and ATP levels were maintained.
Oxidative phosphorylation in mitochondria is the pri-
mary source of ATP production in the heart. CK reaction
is important in energy metabolism as it catalyzes the
interconversion of PCr and ADP with Cr and ATP. This
facilitates the transfer of high-energy phosphates from
mitochondria (where ATP is produced) to myofibrils
(where ATP is consumed) and enables the return of prod-
ucts to mitochondria for rephosphorylation (Lipskaya
2001; Wallimann et al. 2011). In case of impaired oxida-
tive phosphorylation the ATP concentration in the cytosol
is maintained at the expense of PCr resulting in a reduced
PCr/ATP ratio. The PCr/ATP ratio is therefore routinely
used as a marker of myocardial energy balance in research
and clinical studies. MRS studies in both type I and type
II diabetic human subjects have shown lower PCr/ATP
ratio suggesting reduced energy production (Metzler et al.
2002; Scheuermann-Freestone et al. 2003). In one study
the decrease in PCr/ATP was found to be proportional to
the degree of diastolic dysfunction, suggesting a role for
impaired cardiac mitochondrial energetics (Diamant et al.
2003). To our knowledge, this study is the first to demon-
strate reduced [PCr] and PCr/ATP ratio in an animal
model of T2DM. These results are in contrast to two
studies that reported unchanged PCr/ATP in perfused
type I diabetic rat hearts (Matsumoto et al. 1995; Spindler
et al. 1999). The difference could be due to the severity,
duration, and/or the etiology of diabetes. Our study is in
good agreement with several other reports which demon-
Table 1. Animal characteristics in Zucker Diabetic Fatty (ZDF) obese and lean counter parts.
Nondiabetic Diabetic
Baseline Stress Baseline Stress
n 10 6 10 8
Weight (g) 364  88 387  92 382  42 391  43
Heart Rate (bpm) 314  16* 433  26* 302  30* 415  34*
Blood glucose (mmol/L) 6.69  0.95# 6.57  0.87# 20.20  3.25# 20.94  2.38#
*P < 0.05 within group (baseline vs. stress).
#P < 0.05 between groups (nondiabetic vs. diabetic).
Values are represented as mean  SD. P < 0.05 was considered significant.
A B C
Figure 1. (A) 1H reference MR image of the two compartment phantom. Each compartment is about 0.5 cm deep. The RF coil was placed
directly below the phantom. (B) 31P spectrum acquired in the absence of the suppression band showing distinct resonances from the two
phosphate solutions. The Na2HPO4 resonance is larger as it is closer to the RF coil. (C) Example of spectrum acquired when the suppression
band is placed on the bottom phantom containing Na2HPO4. The resonance signal from Na2HPO4 is almost completely eliminated.
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strated reduced PCr and ATP in STZ (insulin-deficient
type I) diabetic rat hearts (Savabi and Kirsch 1991;
Stroedter et al. 1995; Jilkina et al. 2008).
An important finding of this study is that the forward
CK reaction rate constant measured in vivo is about 50%
higher at baseline in diabetic myocardium when com-
pared to controls. This is in contrast with previous stud-
A B
C D
Figure 2. (A) Sagittal and (B) axial reference images of the rat heart. A small fiducial indicating the coil center is visible in the images. Images
also show the placement of saturation band. (C) Stacked plot of spectra is displayed. The duration (s) of saturation of c-ATP is shown on the
right. For clarity duration is displayed for every alternate spectrum. c-ATP is visible in the spectrum when no saturation is applied (t = 0 s).
2,3-diphosphoglycerate (2,3 DPG) resonance arises from the blood in myocardium and other abbreviations are defined in the main text.
(D) Example demonstrating the fitting of the saturation transfer equation to the PCr resonance area.
A B
Figure 3. (A) PCr resonance area represented MU. The hearts of diabetic rats had significantly lower [PCr] compared to age-matched lean rats.
(B) PCr/ATP ratio in diabetic myocardium was significantly lower when compared with age-matched controls. Dobutamine infusion did not
result in any changes in [PCr], or PCr/ATP ratio. Unpaired student t-test was used to determine group differences.
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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ies which reported about 30% reduction in isolated per-
fused type I diabetic rat hearts (Matsumoto et al. 1995;
Spindler et al. 1999). These differences could be due to
several factors. The results obtained in perfused explanted
hearts may not reflect the metabolism of the heart in live
animals. In particular, the spontaneous heart rate
reported in diabetic heart was about 30% lower and the
rate pressure product (RPP) was about half that found in
control hearts (Jilkina et al. 2008; Miki et al. 2013). This
could account for the reduced CK flux since CK reaction
kinetics are coupled to workload (Bittl and Ingwall 1985).
In addition, in these previous studies the inorganic phos-
phate concentration ([Pi]) was more than double in the
diabetic myocardium relative to healthy hearts. High [Pi]
has been associated with ischemia and a fall in developed
pressure, which could reduce ATP production via CK (El-
liott et al. 1994; He et al. 1997). Finally, the free energy
of ATP hydrolysis is proportional to log[(ATP)/(ADP)x
(Pi)]; therefore the high levels of Pi may reflect a low-
energy state in these perfused hearts.
Several studies using biochemical assays have reported
decreased CK activity and altered isoenzyme distribution
in streptozotocin (STZ)-treated rat hearts (Khuchua et al.
1989; Popovich et al. 1989; Awaji et al. 1990; Spindler
et al. 1999). Reduced CK activity would mean lower kf,
whereas we observed increased kf in this study. However,
in a recent study Lin et al. (2009) examined the regula-
tion of M-CK isoenzyme in diabetic rat hearts. They
reported that although the content of CK isoenzyme was
reduced by 34% the phosphorylation of M-CK was
reduced by 71% in diabetic hearts compared to controls,
much greater than the decrease in the expression of
enzyme. As a result, the forward activity of CK reaction
was increased by about 70% in hearts from diabetic rats.
A 50% increase in CK activity was also reported in left
ventricles of 8-week diabetic rat hearts (Somjen et al.
2006). These reports are in agreement with our results
where kf is increased by about 50% at baseline in diabetic
heart. One possible explanation for the reduced total CK
activity observed in some previous studies (Khuchua et al.
1989; Popovich et al. 1989; Awaji et al. 1990; Spindler
et al. 1999) might be due to the use of different biochem-
ical assays in which reverse CK activity could have been
measured.
Interestingly, whereas the CK reaction rate constant
was different the diabetic and control hearts, CK flux was
similar in the two groups due to a reduced [PCr] concen-
tration in the diabetic hearts. Reduced [PCr] might indi-
cate mitochondrial dysfunction, as previous studies in
diabetic rodent hearts have demonstrated reduced mito-
chondrial respiration and ATP synthesis (Kuo et al. 1983,
1985; Boudina et al. 2005). The heart rate in the two
groups was indistinguishable at baseline indicating com-
parable baseline workload therefore the increase in kf
might represent a mechanism to maintain cytosolic ATP
at the expense of PCr. Both groups responded likewise to
the high workload with similar increase in the heart rate
and CK reaction rate constant. The [PCr] was also indis-
tinguishable pre- and postdobutamine infusion in control
heart. These results indicate that under these conditions
CK system does not limit the ability to generate ATP for
cardiac work.
In line with diabetic rat heart myocardium contradic-
tory results have been reported in CK activity in pressure
in left ventricle after pressure overload. A recent study
using 31P MR spectroscopy demonstrated ~30% reduction
in kf and ~50% reduction in CK flux in heart failure
caused by pressure overload after 7 to 8 weeks of thoracic
aortic constriction (Gupta et al. 2011). In contrast, two
previous studies showed increase in steady-state levels of
M and B creatine kinase subunit and also mitochondrial
creatine kinase mRNA and concomitant increase in total
A B C
Figure 4. (A) Heart rate at rest was similar between the two groups. Dobutamine caused similar (about 40%) increase in the heart rate in
both groups. (B) Intrinsic PCr relaxation rate constant (R1) was indistinguishable between the groups at rest and stress. (C) Forward CK reaction
rate constant (kf) was significantly higher at rest in diabetic rat heart as determined by unpaired t-test. Number of animals in each group are
given in Table 1. Increase in cardiac work resulted in similar increases in kf (~0.12 s
1) in both groups.
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CK activity (Meerson and Javich 1982; Fontanet et al.
1991). These changes were observed early after aortic
banding, before left ventricle hypertrophy ensued. Studies
with longer term exposure to pressure showed normal CK
activity (Vatner and Ingwall 1984; Younes et al. 1985;
Pauletto et al. 1989). Although the reasons for these dif-
ference have not been examined but it can be speculated
that initial increased energy requirements in pressure
overload leads to increased CK activity as an adaptive
response to hemodynamic stress. As hypertrophy ensues
the CK enzyme activity decreases toward control levels.
When heart failure develops the CK flux regresses further
and may lead to deficit in ATP delivery especially at high
workloads. A similar time course in CK activity can be
speculated in case of DCM. Numerous metabolic and
pathophysiological stimuli are involved in its development
finally leading to systolic and diastolic left ventricular
(LV) dysfunction (Fang et al. 2004; Voulgari et al. 2010).
An early increase in CK flux could be a compensatory
mechanism to support initial metabolic and structural
remodeling of myocardium eventually becoming mal-
adaptive and leading to heart dysfunction.
There are several limitations that need mentioned. We
did not measure heart function in this study therefore
cannot draw any conclusions about the relationship
between the CK reaction kinetics and cardiac function.
Previous studies have reported enhanced, similar, and
reduction in heart function in ZDF rats (Fredersdorf et al.
2004; van den Brom et al. 2010; Daniels et al. 2012). The
reasons for these differences are not clear perhaps dura-
tion of diabetes, experimental conditions, and anesthetic
mechanism could all potentially contribute to these differ-
ences. We also did not measure blood pressure in these
rats and therefore could not calculate rate pressure prod-
uct as an indicator of cardiac work. However, the heart
rate of the two groups responded similarly to dobutamine
administration, making it reasonable to assume that the
workload was elevated similarly. Additionally, no direct
biochemical estimates of CK isoenzyme concentrations
were made. Surprisingly reports of CK isoenzyme concen-
tration/activity in ZDF rats hearts are lacking therefore
we cannot comment on the relationship between the CK
isoenzymes and CK flux measured by 31P MRS. Addi-
tional time course studies determining the direct relation-
ship between CK isoenzymes, CK flux, and heart function
would be needed to answer these questions.
From an experimental perspective it is conceivable that
there could be contaminating signal arising from other
tissues (i.e., stomach and gut). To get assurance that this
contamination was small we did imaging experiments
with a similar sized proton coil and the signal was
primarily restricted to the heart. We cannot rule out pres-
ence of lung in the sensitive area of RF coil that does not
contribute to 31P signal. As a consequence we were not
able to directly quantify PCr and ATP concentrations in
the heart. However, PCr/ATP ratio reported uses ATP as
an internal standard and thus is independent of different
contribution volumes and coil loading. In 31P MRS the
most commonly used reference is in vivo [ATP], which
has been shown to be very consistent across species and
ATP levels remain normal in myocardium until advanced
stages of heart failure (Neubauer 1999; Hitchins et al.
2001; Kemp et al. 2007; El-Sharkawy et al. 2013). We
have also employed the use of this standard assumption
to calculate in vivo metabolite concentrations and this
assumption is justified given the wealth of published
reports.
In summary, the present study demonstrates that the
PCr content is reduced in type II diabetic rat hearts,
indicative of impairment in mitochondrial ATP produc-
tion. The forward CK reaction rate constant is elevated,
possibly reflecting a compensatory mechanism to support
increased flux through the CK shuttle needed to support
cardiac work. We did not observe any fall in PCr content
with increased cardiac work. CK reaction velocity
increased in both diabetic and control hearts to maintain
constant ATP content at higher work.
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